Corrigendum to “Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study” [Asian J. Psychiatry 85 (2023) 103613] (Asian Journal of Psychiatry (2023) 85, (S1876201823001685), (10.1016/j.ajp.2023.103613))

The authors regret. First, To change the affiliation of Jin Jang^e. ^eDepartment of Psychiatry, Bugok National Hospital, Changyeong, the Republic of Korea. to ^eDepartment of Psychiatry, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea. Second, There is a typo error in the conclusion paragraph of Abstract, Clinicians typically prescribe mood stabilizers as empirically supported treatment to manage mood symptoms in patients with diagnoses other than bipolar disorders, though there is on official indication for these disorders. The costs and benefits of this add-on symptomatic treatment warrant further investigation. Please revise it as Clinicians typically prescribe mood stabilizers as empirically supported treatment to manage mood symptoms in patients with diagnoses other than bipolar disorders, though there is no official indication for these disorders. The costs and benefits of this add-on symptomatic treatment warrant further investigation. The authors would like to apologise for any inconvenience caused. Thank you for your kind help.